DBC-1 (H-2) Antibody sc-166733 from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

DBC-1 (H-2) Antibody

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
DBC-1 (H-2) Antibody

Santa Cruz Biotechnology, Inc.'s DBC-1 (H-2) Antibody is a Mouse monoclonal antibody. The DBC-1 (H-2) Antibody was generated using CCAR2 as the antigen. It reacts with Homo Sapiens, Human, Mouse, and Rat. This antibody has been shown to work in applications such as: EIA, Immunoassay, Precipitation, ELISA, Immunofluorescence, Immunohistochemistry - fixed, Immunoprecipitation, and Western Blot.

Description

Product Type: 57805

Gene ID: 219158

Product Specs
ItemDBC-1 (H-2) Antibody
CompanySanta Cruz Biotechnology, Inc.
Price $316.00Supplier Page View Company Product Page
Catalog Numbersc-166733
Quantity200 µg/ml
ApplicationsWB, IP, IF, IHC(P), ELISA
Reactivitymouse, rat, human
FormatPurified
Conjugate/TagUnconjugated
Antibody TypePrimary Antibodies
CloneH-2
Hostmouse
TargetDBC-1
IsotypeIgG3
NCBI Gene AliasesKIAA1967, p30 DBC, mKIAA1967, p30DBC, 2610301G19Rik, DBC1, Dbc1, DBC-1, NET35
ClonalityMonoclonal
NCBI Full Gene Namecell cycle and apoptosis regulator 2, cell cycle activator and apoptosis regulator 2

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) CCAR2 promotes a malignant phenotype of osteosarcoma through Wnt/β-catenin-dependent transcriptional activation of SPARCBiochemical and biophysical research communicationsNovember 26, 2021Chen L, Zhou SJ, Xu Y, Liao QM, Zou YS, Pei H.

(2) DBC1/CCAR2 is involved in the stabilization of androgen receptor and the progression of osteosarcomaScientific reportsAugust 7, 2015Wagle S, Park SH, Kim KM, Moon YJ, Bae JS, Kwon KS, Park HS, Lee H, Moon WS, Kim JR, et al.

(3) Deleted in breast cancer 1 plays a functional role in adipocyte differentiationAmerican journal of physiology. Endocrinology and metabolismApril 1, 2015Moreno-Navarrete JM, Moreno M, Vidal M, Ortega F, Serrano M, Xifra G, Ricart W, Fernández-Real JM.

(4) Modification of DBC1 by SUMO2/3 is crucial for p53-mediated apoptosis in response to DNA damageNature communicationsNovember 18, 2014Park JH, Lee SW, Yang SW, Yoo HM, Park JM, Seong MW, Ka SH, Oh KH, Jeon YJ, Chung CH.

Be the First to Write a Review!